JP2011511762A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511762A5
JP2011511762A5 JP2010540846A JP2010540846A JP2011511762A5 JP 2011511762 A5 JP2011511762 A5 JP 2011511762A5 JP 2010540846 A JP2010540846 A JP 2010540846A JP 2010540846 A JP2010540846 A JP 2010540846A JP 2011511762 A5 JP2011511762 A5 JP 2011511762A5
Authority
JP
Japan
Prior art keywords
hedgehog
tissue
antibody
binding
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010540846A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011511762A (ja
JP5715420B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/088059 external-priority patent/WO2009086324A1/en
Publication of JP2011511762A publication Critical patent/JP2011511762A/ja
Publication of JP2011511762A5 publication Critical patent/JP2011511762A5/ja
Application granted granted Critical
Publication of JP5715420B2 publication Critical patent/JP5715420B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010540846A 2007-12-28 2008-12-22 抗ヘッジホッグ抗体 Expired - Fee Related JP5715420B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1723207P 2007-12-28 2007-12-28
US61/017,232 2007-12-28
US9986408P 2008-09-24 2008-09-24
US61/099,864 2008-09-24
PCT/US2008/088059 WO2009086324A1 (en) 2007-12-28 2008-12-22 Anti-hedgehog antibodies

Publications (3)

Publication Number Publication Date
JP2011511762A JP2011511762A (ja) 2011-04-14
JP2011511762A5 true JP2011511762A5 (enExample) 2012-02-16
JP5715420B2 JP5715420B2 (ja) 2015-05-07

Family

ID=40433914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010540846A Expired - Fee Related JP5715420B2 (ja) 2007-12-28 2008-12-22 抗ヘッジホッグ抗体

Country Status (7)

Country Link
US (3) US8030454B2 (enExample)
EP (1) EP2235063B1 (enExample)
JP (1) JP5715420B2 (enExample)
AU (1) AU2008345246B2 (enExample)
CA (1) CA2709399C (enExample)
ES (1) ES2551736T3 (enExample)
WO (1) WO2009086324A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102573832B (zh) * 2009-08-25 2015-07-22 阿布拉科斯生物科学有限公司 利用紫杉烷和刺猬抑制剂的纳米颗粒组合物的联合治疗
US11644471B2 (en) 2010-09-30 2023-05-09 Ablynx N.V. Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
US8945627B2 (en) 2011-05-05 2015-02-03 Wisconsin Alumni Research Foundation Micelles for the solubilization of gossypol
PH12022550313A1 (en) 2011-06-23 2023-01-23 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
US9814703B2 (en) 2013-11-14 2017-11-14 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating cancer by activation of BMP signaling
US11867696B2 (en) * 2015-02-06 2024-01-09 Cell Idx, Inc. Antigen-coupled immunoreagents
CN104645358A (zh) * 2015-02-09 2015-05-27 中国人民解放军第二军医大学 一种胰腺癌靶向的纳米级超声造影剂及其制备方法和应用
US10548908B2 (en) 2016-09-15 2020-02-04 Nostopharma, LLC Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification
CN112805299B (zh) 2018-10-05 2025-09-16 西雅图儿童医院以西雅图儿童研究机构名义经营 针对原发性免疫缺陷、胱氨酸病和威尔逊病的新生儿筛查
US11940448B2 (en) 2020-03-31 2024-03-26 Seattle Children's Hospital Proteomic screening for lysosomal storage diseases
US12523662B2 (en) 2020-04-02 2026-01-13 Seattle Children's Hospital Antibodies that specifically bind peptides associated with the primary immunodeficiencies: Wiskott-Aldrich syndrome and x-linked agammaglobulinemia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4946783A (en) 1987-01-30 1990-08-07 President And Fellows Of Harvard College Periplasmic protease mutants of Escherichia coli
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
EP0604580A1 (en) 1991-09-19 1994-07-06 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES
US7060450B1 (en) * 1993-12-30 2006-06-13 President And Fellows Of Harvard College Screening assays for agonists and antagonists of the hedgehog signaling pathway
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
JPH114695A (ja) * 1997-04-25 1999-01-12 Hayashibara Biochem Lab Inc ヘッジホッグ蛋白質
AU767066B2 (en) * 1999-03-03 2003-10-30 Curis, Inc. Methods of modulating lipid metabolism and storage
IL153115A0 (en) * 2000-06-16 2003-06-24 Curis Inc Angiogenesis-modulating compositions and uses
US7498304B2 (en) * 2000-06-16 2009-03-03 Curis, Inc. Angiogenesis-modulating compositions and uses
CA2425356C (en) * 2000-10-13 2015-10-06 Curis, Inc. Hedgehog antagonists, methods and uses related thereto
ES2707393T3 (es) * 2004-03-26 2019-04-03 Curis Inc Moduladores de interferencia de ARN de señalización de hedgehog y usos de los mismos

Similar Documents

Publication Publication Date Title
JP2011511762A5 (enExample)
AU2016233309B2 (en) Anti-MUC16 antibodies and uses thereof
EP2507635B1 (en) Biochemical serum biomarker
JP2016536330A5 (enExample)
KR20140107615A (ko) 엑소좀 검출용 모노클로날 항체
ES2909961T3 (es) Biomarcadores de células senescentes
Li et al. Cytoskeleton-associated protein 4, a promising biomarker for tumor diagnosis and therapy
CN115976196B (zh) ErbB3作为肺动脉高压生物标志物和治疗靶点的应用
WO2011150994A2 (en) Serum and tissue biomarkers of human hcc
WO2010131704A1 (ja) 内臓脂肪型肥満の検査薬およびその利用
US20190023781A1 (en) Therapeutic drug for malignant tumors
WO2013021088A2 (es) Métodos y productos para el diagnóstico in vitro, pronóstico in vitro y desarrollo de fármacos contra carcinomas invasivos
JP2024037767A (ja) 改変型線維芽細胞成長因子21(fgf-21)を用いる非アルコール性脂肪性肝炎(nash)の処置方法
AU2010268979B2 (en) New tumor marker
WO2015149450A1 (zh) Ehd2抗体及其在制备乳腺癌免疫组化检测试剂中的应用
JP5752419B2 (ja) 新規ヒト転移性腫瘍関連分子、活性化遺伝子およびタンパク質を検出する方法ならびに遺伝子発現を妨害する方法
JP2003510032A5 (enExample)
US20160264655A1 (en) Treating cancers with drugs targeting CREB3L1
EP2475685B1 (en) An isolated monophosphorylated peptide derived from human alpha-enolase useful for diagnosis and treatment of pancreatic adenocarcinoma, antibodies directed against the said monophosphorylated peptide, and uses thereof
JP6729917B2 (ja) EphA2 N末端フラグメント抗体
US20090239255A1 (en) Odontogenic ameloblast-associated protein as a tumor biomarker
JP5830329B2 (ja) 腎障害の新規マーカー
CN118067996B (zh) 一种PDK1 Nedd8修饰的结直肠癌标志物及应用
JP5041978B2 (ja) 胃癌及び/又は大腸癌の検出方法
Jung et al. Decreased expression of TFF2 and gastric carcinogenesis